Molecular Biology Enzymes, Reagents, And Kits Market To Reach $44.67 Billion By 2030

Molecular Biology Enzymes, Reagents, and Kits Market Growth & Trends

The global molecular biology enzymes, reagents, and kits market size is expected to reach USD 44.67 billion by 2030, registering a CAGR of 9.65%, according to a new report by Grand View Research, Inc The growth of the market globally can be attributed to continuous advancement in technologies in the molecular biology field, the prevalence of infectious and chronic diseases, increased usage of sequencing technologies and growing omics-based research activities.

The COVID-19 pandemic exponentially increased the demand for molecular biology enzymes, reagents, and kits, and the continuous rise in cases worldwide kept the demand on the higher side. Many market players, healthcare organizations, and academic and research institutes were actively engaged in the development of vaccines and they increased the research for repurposing the existing therapeutics for the treatment of COVID-19 infection. This continuous R&D activity is expected to boost the demand for these products in the coming years. Moreover, in an effort to detect the SARS-CoV-2 virus faster, many new products were launched by the key market players, such as RNA extraction kits. For example, in June 2020, Omega Bio-tek, Inc. announced the launch of its “Mag-Bind Viral RNA Xpress Kit” for RNA isolation in a reliable and rapid manner from the nasopharyngeal swab of patient samples.

Continuous funding and investments in the field of synthetic biology and multi-omics are expanding the field of biotechnology. As per a press release in March 2022, The Bristol Centre for Engineering Biology, BrisEngBio, is an institute that supports research and discovery in synthetic biology. It is a UKRI-funded research center that has published over 325 research papers, collaborated with 8 biotech companies, and received an additional USD 117.90 million for research. This rapidly advancing field of synthetic biology and multi-omics will result in more extensive adoption of molecular biology, enzymes, kits, and reagent products, which serve as educational tools. And this adoption rate further enhances the development of innovative methods such as drug discovery, diagnostics development, and gene therapies manufacturing, hence driving the market significantly.

The key market players are expanding their global presence through never-ceasing product launches and sustained technological developments. Acquisitions, partnerships, collaborations, and manufacturing expansions are also some of the business strategies taken up by the key players to drive revenue generation in the market. For example, in January 2022, Illumina, Inc. announced a partnership with SomaLogic to develop a product by integrating Illumina’s NGS technology with SomaScan Proteomics Assay. This partnership bolsters the rapidly growing high-throughput segment of the proteomics market.

 Request a free sample copy or view the report summary: Molecular Biology Enzymes, Reagents, and Kits Market Report

Molecular Biology Enzymes, Reagents, and Kits Market Report Highlights

• By product, the kits and reagents held the largest share in 2022. The launch of new kits and reagents in response to the pandemic is one of the key reasons fueling the growth. Moreover, the repeated use of molecular biology kits and reagents in laboratory setups contributes to the growth

• By application, sequencing accounted for the largest share in 2022 due to the introduction of single-cell sequencing and the leading presence of NGS. Use of NGS for analysis of genomics, tumor diagnostics, and biomarker discovery fuels the segment growth

• By end-use, the pharma and biotech segment held the largest share in 2022. The presence of drug development pipelines, clinical trials, and continuous R&D activities require huge usage of molecular biology enzymes, kits, and reagents, thus leading to the segment growth

• North America held the largest revenue share in 2022. This is attributed to the presence of numerous key pharmaceutical and biotechnology companies in the U.S. Furthermore, the prevalence of diseases in this region and increased use of molecular diagnostics contribute to revenue generation

Molecular Biology Enzymes, Reagents, and Kits Market Segmentation

Grand View Research has segmented the global molecular biology enzymes, reagents, and kits market based on product, application, end-use, and region:

Molecular Biology Enzymes, Reagents, and Kits Product Outlook (Revenue, USD Million, 2018 - 2030)

• Kits & Reagents

• Enzymes

Molecular Biology Enzymes, Reagents, and Kits Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cloning

• Sequencing

• PCR

• Epigenetics

• Restriction Digestion

• Other Applications

Molecular Biology Enzymes, Reagents, and Kits End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharma & Biotech

• Academic & Research

• Hospital & Diagnostics

• Others

Molecular Biology Enzymes, Reagents, and Kits Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • U.K.

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

List of Key Players in Molecular Biology Enzymes, Reagents, and Kits Market

• Thermo Fisher Scientific, Inc.

• Illumina, Inc.

• Agilent Technologies, Inc.

• QIAGEN

• Promega Corporation

• New England Biolabs

• Merck KGaA

• F. Hoffmann-La Roche Ltd.

• Bio-Rad Laboratories, Inc.

• Takara Bio, Inc.

• LGC Limited